Patent details

EP1729803 Title: THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES

Basic Information

Publication number:
EP1729803
PCT Application Number:
PCT/US/2004/037430
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP048106314
PCT Publication Number:
WO/2005/102387
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
THERAPEUTIC USE OF ANTI-CS1 ANTIBODIES
French Title of Invention:
UTILISATION THERAPEUTIQUE DES ANTICORPS ANTI-CS1
German Title of Invention:
THERAPEUTISCHE VERWENDUNG VON ANTI-CS1-ANTIKÖRPERN
SPC Number:

Dates

Filing date:
08/11/2004
Grant date:
29/09/2010
EP Publication Date:
29/09/2010
PCT Publication Date:
03/11/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/12/2006
EP B1 Publication Date:
29/09/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/11/2010
Expiration date:
08/11/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/12/2010
 
 

Name:
Abbott Biotherapeutics Corp.
Address:
1500 Seaport Boulevard, Redwood City CA 94063, United States (US)

Inventor

1

Name:
LIU Gao
Address:
United States (US)

2

Name:
WILLIAMS Marna
Address:
United States (US)

3

Name:
LANDOLFI Nicholas F.
Address:
United States (US)

4

Name:
TSO J. Yun
Address:
United States (US)

Priority

1

Priority Number:
557620 P
Priority Date:
29/03/2004
Priority Country:
United States (US)

2

Priority Number:
557621 P
Priority Date:
29/03/2004
Priority Country:
United States (US)

3

Priority Number:
557622 P
Priority Date:
29/03/2004
Priority Country:
United States (US)

4

Priority Number:
842011
Priority Date:
07/05/2004
Priority Country:
United States (US)

5

Priority Number:
982357
Priority Date:
05/11/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;
Filing date Document type Number of pages